Resultados de búsqueda - Nature Publishing Group :: Descubridor de recursos de la Universidad Veracruzana

81

Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS

por Tidd, D.M.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso

Texto

Cargando…

Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS

82

A Dictionary of Modern Medicine

por Twentyman, P.R.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso

Texto

Cargando…

83

Metabolism of the bioreductive cytotoxin SR 4233 by tumour cells: enzymatic studies.

por Wang, J., Biedermann, K. A., Wolf, C. R., Brown, J. M.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Metabolism of the bioreductive cytotoxin SR 4233 by tumour cells: enzymatic studies.

84

Cortisol is transported by the multidrug resistance gene product P-glycoprotein.

por van Kalken, C. K., Broxterman, H. J., Pinedo, H. M., Feller, N., Dekker, H., Lankelma, J., Giaccone, G.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Cortisol is transported by the multidrug resistance gene product P-glycoprotein.

85

Dosage and cycle effects of dacarbazine (DTIC) and fotemustine on O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells.

por Lee, S. M., Thatcher, N., Dougal, M., Margison, G. P.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Dosage and cycle effects of dacarbazine (DTIC) and fotemustine on O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells.

86

The Macrophage

por Embleton, M.J.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso

Texto

Cargando…

87

Breast cancer prognosis is poor when total plasminogen activator activity is low.

por Yamashita, J., Ogawa, M., Inada, K., Yamashita, S., Nakashima, Y., Saishoji, T., Nomura, K.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Breast cancer prognosis is poor when total plasminogen activator activity is low.

88

Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

por Foulkes, W. D., Campbell, I. G., Stamp, G. W., Trowsdale, J.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

89

Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans.

por Bergenheim, A. T., Gunnarsson, P. O., Edman, K., von Schoultz, E., Hariz, M. I., Henriksson, R.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans.

90

Multiple primary cancers in the Vaud Cancer Registry, Switzerland, 1974-89.

por Levi, F., Randimbison, L., Te, V. C., Rolland-Portal, I., Franceschi, S., La Vecchia, C.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Multiple primary cancers in the Vaud Cancer Registry, Switzerland, 1974-89.

91

A daily diary for quality of life measurement in advanced breast cancer trials.

por Fraser, S. C., Ramirez, A. J., Ebbs, S. R., Fallowfield, L. J., Dobbs, H. J., Richards, M. A., Bates, T., Baum, M.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

A daily diary for quality of life measurement in advanced breast cancer trials.

92

Completeness of cancer registration in England and Wales: an assessment based on 2,145 patients with Hodgkin's disease independently registered by the British National Lymphoma Inv...

por Swerdlow, A. J., Douglas, A. J., Vaughan Hudson, G., Vaughan Hudson, B.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Completeness of cancer registration in England and Wales: an assessment based on 2,145 patients with Hodgkin's disease independently registered by the British National Lymphoma Investigation.

93

Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.

por Modjtahedi, H., Eccles, S., Box, G., Styles, J., Dean, C.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.

94

Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.

por Kobayashi, H., Ohi, H., Fujii, T., Terao, T.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.

95

Preclinical, phase I and pharmacokinetic studies with the dimethyl phenyltriazene CB10-277.

por Foster, B. J., Newell, D. R., Carmichael, J., Harris, A. L., Gumbrell, L. A., Jones, M., Goodard, P. M., Calvert, A. H.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Preclinical, phase I and pharmacokinetic studies with the dimethyl phenyltriazene CB10-277.

96

The clonogenic growth of advanced breast tumour lesions adds no value to that of established clinical prognosticators for survival.

por Hug, V., Polyzos, A., Tucker, S., Thames, H.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

The clonogenic growth of advanced breast tumour lesions adds no value to that of established clinical prognosticators for survival.

97

Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.

por Fraser, S. C., Dobbs, H. J., Ebbs, S. R., Fallowfield, L. J., Bates, T., Baum, M.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.

98

Apoptosis (the 1992 Frank Rose Memorial Lecture).

por Wyllie, A. H.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Apoptosis (the 1992 Frank Rose Memorial Lecture).

99

A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.

por Gietema, J. A., de Vries, E. G., Sleijfer, D. T., Willemse, P. H., Guchelaar, H. J., Uges, D. R., Aulenbacher, P., Voegeli, R., Mulder, N. H.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.

100

Chemotherapeutic efficacy of the protein-doxorubicin conjugates on multidrug resistant rat hepatoma cell line in vitro.

por Ohkawa, K., Hatano, T., Tsukada, Y., Matsuda, M.
Publicado 1993

“…Nature Publishing Group…”

Enlace del recurso
Enlace del recurso

Texto

Cargando…

Chemotherapeutic efficacy of the protein-doxorubicin conjugates on multidrug resistant rat hepatoma cell line in vitro.

Limitar resultados